CN1157166A - Xuefukang medicine - Google Patents

Xuefukang medicine Download PDF

Info

Publication number
CN1157166A
CN1157166A CN 96118611 CN96118611A CN1157166A CN 1157166 A CN1157166 A CN 1157166A CN 96118611 CN96118611 CN 96118611 CN 96118611 A CN96118611 A CN 96118611A CN 1157166 A CN1157166 A CN 1157166A
Authority
CN
China
Prior art keywords
root
radix
chinese
fruit
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 96118611
Other languages
Chinese (zh)
Inventor
温顺明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 96118611 priority Critical patent/CN1157166A/en
Publication of CN1157166A publication Critical patent/CN1157166A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a Chinese medicine preparation for curing leukemia, including capsule and honey pill. The medicinal composition of the capsule is composed of the Chinese medicinal materials of coptis root, scutellaria root, phellodendron bark, isatis leaf, indigo, gardenia fruit, lonicera flower, forsythia fruit, bearded scutellaria, hedyotis, rehmannia root, scrophularia root, moutan bark, red peony root, water buffalo horn and prunella spike, etc., and the medicinal composition of the honey pill is composed of 32 Chinese medicines of astragalus root, codonopsis root, poria, ovate atractylodes root, Chinese angelica root and fresh rehmannia root, etc..

Description

The multiple health of blood
The present invention relates to the multiple health of the leukemic pure Chinese medicine-blood of a kind of treatment.
Leukemia is commonly called as " leukemia ", it is a kind of hemopoietic system malignant tumor, dies from half that leukemia person almost accounts for various cancer mortality sums especially in the child, is a kind of serious threat human life's disease, bring very big difficulty for society and family, bring very big misery to the patient.At present, medical profession based on chemotherapy, adopts cyclophosphamide, cytosine arabinoside, vincristine to leukemia.Drug therapys such as 6-mercaptopurine, methotrexate, but all exist the curative effect cycle long, to shortcomings such as the patient body damage are big.Though the leukemic bibliographical information of Chinese traditional treatment is also arranged, does not see that always the product of satisfactory effect occurs.
The object of the invention provides the multiple health of the leukemic pure Chinese medicinal preparation-blood of a kind of treatment.
Before explanation the present invention fills a prescription composition, theoretical foundation of the present invention at first is described once:
The leukemia morbidity has gently to be had heavily, and it is slow that the oncoming force has urgency to have, and the course of disease has the long weak point that has." asthenia " " blood disorder " " epidemic febrile disease " " disease the is long-pending " categories such as " sucutaneous nodule " that all belongs to the traditional Chinese medical science.
The inventor thinks that leukemic therapeutic scheme should respect the uniformity of body, relies on body and itself " from treatment functions ", solves the contradiction of self.In other words, promptly to follow and excite the instinct of vital movement power.On the basis of improving physiological immunity and regulatory function, reach the purpose of treatment.The treatment rule of the following aspects specifically: (one) the four methods of diagnosis and eight key links, dialectical executing controlled.Leukemia exists a common denominator, is exactly that kidney yin is lost.The phase hyperactivity of fire, accumulate that poison is dark, blood is hindered, Chong and Ren channel disorder.Therapeutic Method is nourishing kidney-yin, reducing the minister-fire, the benefit gate of vitality, separates and accumulate poison, accent towards appointing, enriches blood and change marrow.Wherein: nourishing kidney-yin is to expand the resource of body fluid and cellular biochemical and strengthen its resting state, thereby prolongs the life cycle of bone marrow and blood.Reducing the minister-fire promptly lowers the speed of cell cycle motion, that is is to alleviate its hypertrophy and metabolism, so as to reducing its consumption to bone marrow and blood.Nourishing kidney-yin and reducing the minister-fire make the movable recovery of cycle of body normal, and then leukocytic hypertrophy is restricted, juvenile cell is transformed, and other blood also accumulate poison so as to keeping balance, separating, the rule that poison is accumulate in treatment has: send out poison holding thoroughly, find a way out for accumulateing poison, that is to say that off-balancesheet goes out; Heat-clearing and toxic substances removing because the many deficiency of both QI and blood of leukaemic accumulate poison and fall into difficult saturating the sending out of shape, is then used the method for dissipating heat and detoxifying internal diabetes; Set upright removing toxic substances, promptly improve and want body immunity to accumulate poison to change warp and inhibition, transfer to dash and appoint, chong channel is the sea of blood; Correspondent the five internal organs, the conception vessel calmness Tibetan of stinging, the moon of main the whole body.Strengthen to dash appoint a function, in the biochemistry cycle of scalable blood, the mitigation hypertrophy is enriched blood and is changed marrow, and enriching blood is to take stopgap measures, and the blood transfusion of doctor trained in Western medicine also is to take stopgap measures emergently, and because of the regeneration of blood depends on marrow, and the source of disease of leukemia is marrow, so the method for radical cure should be changed marrow.This change the bone marrow transplantation that marrow is not a doctor trained in Western medicine.The Chinese medicine clothing is a kidney governing bones, and bone is given birth to marrow, with blood circulation promoting and blood stasis dispelling, through the metabolism in a period, is exactly the marrow method of changing progressively with the kidney invigorating, detoxifcation, warp.
Need stress, also be inventor's novel viewpoint, is the reducing the minister-fire and the benefit gate of vitality.This appears contradiction, and is also non-actually, and fire is closely bound up with the gate of vitality mutually, and how the no gate of vitality comes mutually fire also.Here can mutually the fire and the relation of the gate of vitality than tabulation and lining.The phase hyperactivity of fire, it is strong to may not be certain the gate of vitality.Mutually fire normal prosperous be phenomenon, if poison is vehement, wouldn't the gate of vitality be burnouted also, poison is vehement and prosperous, as pouring oil on the fire, the people has only without a break, why prohibits to pour oil on the fire and refine also, so need reducing the minister-fire.Fire easily rushes down and can not go out also mutually, thus need mend the gate of vitality again, strengthening and to prolong the effect of reducing the minister-fire, so the benefit gate of vitality is us passing through then of remaining the same from beginning to end.I.e. help is also as asking fire.About the gate of vitality's position, form and function " difficult warp, 36 difficulties " are said: " kidney both, non-all kidneys also, its left person is a kidney, right person is the gate of vitality." Jing-Yue Complete Works says: " and the gate of vitality is the residence of extreme misery for the root of vigour, the cloudy gas of the five internal organs, and non-this can not be grown; YANG of five ZANG-organs gas, non-this can not be sent out." " class is through the attached wing " add: " two kidneys are the gate of vitality all "; " fire from the gater of life, the vigour of meaning " " life-gate water, primordial essence of meaning.Zhao Xianke proposes the gate of vitality for presiding over the kidney-yang of human body the whole body yang-energy.Sun Yikui thinks that then the gate of vitality is an interrenal qi, and invisible matter, for internal organs this, Source of life.As seen the gate of vitality important, mainly the treatment leukemia emphasized again and again of this and modern medicine must be noted immune variation, chemotherapy blindly not; Must note variation of Abwehrkraft des Koepers or the like, saying so in some sense communicates.After all, mend the gate of vitality be in the multiple health series of the invention human blood prescription treatment leukemia process follow through will be then.
According to above theoretical foundation; The multiple health of a kind of leukemic Chinese medicine for the treatment of of the present invention--blood; ,: 8-12 8-12 8-12 25-35 4-8 4-8 10-14 7-11 25-35 25-35 12-17 10-14 4-8 4-8 25-35 25-35 25-35 25-35 10-14 10-14 22-26 22-26 3-7 22-26 2-4 7-10 7-10 60-80 13-17 25-35 10-14 2-4 2-4 : 25-35 13-17 7-11 7-11 8-12 8-12 13-17 10-14 10-14 8-12 7-11 4-7 7-11 4-7 16-20 8-14 20-26 21-26 13-17 13-17 7-11 13-17 4-7 4-7 13-17 4-7 3-5 13-17 25-35 25-35 3-7
Advantage of the present invention is that nontoxic nothing is paid effect, through clinical 2000 many cases of inventor's several years, cure rate 42.3%, effective percentage 90%.
Embodiment 1:
A kind of multiple health of leukemic Chinese medicine-blood for the treatment of; ,: 8 8 8 25 4 4 10 7 25 25 12 10 4 4 25 25 25 25 10 10 22 22 3 22 2 7 7 60 13 25 10 2 2 : 35 17 11 11 12 12 17 14 14 12 11 7 11 7 20 14 26 26 17 17 11 17 7 7 17 7 5 17 35 35 7。
More than form the multiple Kang Jing Henan Medical Univ. of blood animal center animal toxicity be experiment showed, clinical practice safety, belong to nontoxic level medicine.Through clinical nearly 2000 routine leukaemics, cure rate 42.3%, effective percentage 90%.
Embodiment 2:
A kind of leukemic Chinese medicine--multiple health of blood for the treatment of; ,: 12 12 12 35 8 8 14 11 35 35 17 14 8 8 35 35 35 35 14 14 26 26 7 26 4 10 10 80 17 35 14 4 4: 25 13 7 7 8 8 13 10 10 8 7 4 7 4 16 10 20 21 13 13 7 13 4 4 13 4 3 13 25 25 3。

Claims (2)

1. the leukemic Chinese medicine for the treatment of--blood is health again; Be comprised of capsule and honeyed bolus, it is characterized in that: the Traditional Chinese medicine capsule thing forms umber and is: the full worm 2-4 of coptis root 8-12 root of large-flowered skullcap 8-12 golden cypress 8-12 folium isatidis 25-35 indigo naturalis 4-8 mast 4-8 honeysuckle flower 10-14 fructus forsythiae 7-11 Sculellaria barbata 25-35 HERBA HEDYOTIS DIFFUSAE 25-35 dried rhizome of rehmannia 12-17 radix scrophulariae 10-14 root bark of tree peony 4-8 radix paeoniae rubrathe 4-8 cornu bubali 25-35 selfheal 25-35 kelp 25-35 marine alga 25-35 Southern Star 10-14 bulb of fritillary 10-14 turtle shell 22-26 oyster 22-26 peach kernel 3-7 cultivated land 22-26 safflower 2-4 root of herbaceous peony 7-10 Radix Angelicae Sinensis 7-10 cogongrass rhizome 60-80 field thistle 13-17 reed rhizome 25-35 felwort 10-14 river worm 2-4
Close ball Chinese traditional medicine forms umber: a bar halberd of Radix Astragali 25-35 Radix Codonopsis 13-17 Poria cocos 7-11 bighead atractylodes rhizome 7-11 Radix Angelicae Sinensis 8-12 dried rhizome of rehmannia 8-12 cultivated land 13-17 sealwort 10-14 donkey-hide gelatin 10-14 red sage root 8-12 root of herbaceous peony 7-11 radix paeoniae rubrathe 4-7 jujube kernel 7-11 polygala root 4-7 tortoise version 16-20 dogwood fruit 8-14 fruit of Chinese wolfberry 20-26 mulberry fruit 21-26 fruit of glossy privet 13-17 Eclipta prostrata 13-17 7-11 tuber of dwarf lilyturf Chinese yam 13-17 wind-weed 4-7 placenta 4-7 Ganoderma 13-17 royal jelly 4-7 blood scorpion 3-5 pangolin 13-17 white fungus 25-35 black alum 25-35 date 3-7
2. blood according to claim 1 is answered health, it is characterized in that: the Traditional Chinese medicine capsule thing forms umber and is: coptis root 10 roots of large-flowered skullcap 10 golden cypresses 10 folium isatidis 30 indigo naturalis 6 masts 6 honeysuckle flowers 12 fructus forsythiaes 9 Sculellaria barbatas 30 HERBA HEDYOTIS DIFFUSAEs 30 dried rhizome of rehmannia 15 radix scrophulariaes 12 root barks of tree peony 6 radix paeoniae rubrathe 6 cornu bubalis 30 selfheals 30 kelps 30 marine algas 30 Southern Stars 12 bulbs of fritillary 12 turtle shells 24 oysters 24 peach kernels 5 cultivated lands 24 safflowers 3 root of herbaceous peonys 9 Radix Angelicae Sinensis 9 cogongrass rhizomes 75 field thistles 15 reed rhizomes 30 felworts 12 river worms 3 full worms 3
Close ball Chinese traditional medicine forms umber: bar halberd of the Radix Astragali 30 Radix Codonopsis 15 Poria cocos, 9 bighead atractylodes rhizome 9 Radix Angelicae Sinensis, 10 dried rhizome of rehmannia 10 cultivated lands, 15 sealwort 12 donkey-hide gelatin, 12 red sage root 10 root of herbaceous peonys, 9 radix paeoniae rubrathe 6 jujube kernels, 9 polygala root 6 tortoise versions, 18 dogwood fruit 12 fruits of Chinese wolfberry, 24 mulberry fruit 24 fruit of glossy privets, 15 Eclipta prostrata 9 Chinese yam 15 wind-weeds, 6 placentas, 15 tuber of dwarf lilyturf 6 Ganodermas 15 royal jelly 6 blood scorpions 4 pangolins 15 white fungus 30 black alums 30 dates 5
CN 96118611 1996-01-25 1996-01-25 Xuefukang medicine Pending CN1157166A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 96118611 CN1157166A (en) 1996-01-25 1996-01-25 Xuefukang medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 96118611 CN1157166A (en) 1996-01-25 1996-01-25 Xuefukang medicine

Publications (1)

Publication Number Publication Date
CN1157166A true CN1157166A (en) 1997-08-20

Family

ID=5125191

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 96118611 Pending CN1157166A (en) 1996-01-25 1996-01-25 Xuefukang medicine

Country Status (1)

Country Link
CN (1) CN1157166A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1077797C (en) * 1999-12-30 2002-01-16 董伍信 Chinese medicine powder preparation for curing leukemia
CN1098698C (en) * 1998-07-31 2003-01-15 张发誉 Medicinal pill for treating leukemia
CN101095822B (en) * 2007-07-23 2010-06-16 由玺印 Chinese traditional medicine composition for treating leukemia and method of making the same
CN101167962B (en) * 2007-11-02 2010-06-23 潘琳莉 Orally-administered traditional Chinese medicinal formula for treating leukemia
CN101797324A (en) * 2010-02-24 2010-08-11 谷铭 Medicinal composition for treating leukemia
CN101204547B (en) * 2007-12-12 2010-12-15 胡红芳 Peroral Chinese traditional medicine for yangcollaterals injury inducing emptysis
CN102293287A (en) * 2011-06-14 2011-12-28 贾向前 Tea beverage with amendment effect against malaise caused by excess electromagnetic radiation
CN103585471A (en) * 2013-10-18 2014-02-19 张兆玺 Traditional Chinese medicine composition for treating thrombocytopenia
CN103736038A (en) * 2014-02-19 2014-04-23 段寒 Chinese medicine combination for curing leukemia, preparation and application thereof
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
CN109589389A (en) * 2018-12-18 2019-04-09 李天基 A kind of drug and preparation method thereof for treating leukaemia
CN112516235A (en) * 2021-02-01 2021-03-19 马宇振 Pharmaceutical composition for treating leukemia and application thereof

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1098698C (en) * 1998-07-31 2003-01-15 张发誉 Medicinal pill for treating leukemia
CN1077797C (en) * 1999-12-30 2002-01-16 董伍信 Chinese medicine powder preparation for curing leukemia
CN101095822B (en) * 2007-07-23 2010-06-16 由玺印 Chinese traditional medicine composition for treating leukemia and method of making the same
CN101167962B (en) * 2007-11-02 2010-06-23 潘琳莉 Orally-administered traditional Chinese medicinal formula for treating leukemia
CN101204547B (en) * 2007-12-12 2010-12-15 胡红芳 Peroral Chinese traditional medicine for yangcollaterals injury inducing emptysis
CN101797324A (en) * 2010-02-24 2010-08-11 谷铭 Medicinal composition for treating leukemia
CN101797324B (en) * 2010-02-24 2015-09-02 谷铭 One treats leukemic pharmaceutical composition
US9095606B1 (en) 2010-11-13 2015-08-04 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
US9066974B1 (en) 2010-11-13 2015-06-30 Sirbal Ltd. Molecular and herbal combinations for treating psoriasis
CN102293287B (en) * 2011-06-14 2013-03-20 贾向前 Tea beverage with amendment effect against malaise caused by excess electromagnetic radiation
CN102293287A (en) * 2011-06-14 2011-12-28 贾向前 Tea beverage with amendment effect against malaise caused by excess electromagnetic radiation
CN103585471A (en) * 2013-10-18 2014-02-19 张兆玺 Traditional Chinese medicine composition for treating thrombocytopenia
CN103585471B (en) * 2013-10-18 2015-06-10 张兆玺 Traditional Chinese medicine composition for treating thrombocytopenia
CN103736038A (en) * 2014-02-19 2014-04-23 段寒 Chinese medicine combination for curing leukemia, preparation and application thereof
CN103736038B (en) * 2014-02-19 2016-01-20 段寒 Treat leukemic Chinese medicine composition, its preparation and application
CN109589389A (en) * 2018-12-18 2019-04-09 李天基 A kind of drug and preparation method thereof for treating leukaemia
CN112516235A (en) * 2021-02-01 2021-03-19 马宇振 Pharmaceutical composition for treating leukemia and application thereof

Similar Documents

Publication Publication Date Title
CN1169541C (en) Medicine for treating rheumatoid arthritis
CN1157166A (en) Xuefukang medicine
CN1289121C (en) Medicine for promoting ovulation and aiding pregnancy
CN1298370C (en) Kidney benefiting essence culturing pills
CN1298346C (en) Dynamic medicine for channels and collaterals and blood vessel
CN1062157C (en) Hepatitis B curing toxin-dissipating pill
CN1090494C (en) Leukemia converted from aplastic anemia
CN1286518C (en) Chinese medicinal prescription for treating gastropathy
CN1065134C (en) Quick-acting preparation for litholysis
CN102614442B (en) Traditional Chinese drug capsules with effects of immunity enhancing, blood reinforcing and antiemesis
CN1175835C (en) Medicine for treating cervical vertebra disease
CN1459308A (en) Series medicines for treating headache
CN1257745C (en) Chinese medicinal composition for treating typhoid
CN101745080A (en) Chinese patent medicine for treating leukemia
CN101314010A (en) Liquefied clearing pill
CN1174065A (en) Injection for dysfunctional anemia
CN1067271C (en) Capsule for curing hepatitis B
CN1899557A (en) Chinese medicine preparation for treating leukemia
CN1186060C (en) Chinese medicine capsule and adhesive plaster for treating mammary cancer and its preparation method
CN1150014C (en) Lupus erythematosus treating medicine
CN1113804A (en) Antianemic powder and its preparing method
CN105395883A (en) Traditional Chinese medicine for curing anemia
CN107384710A (en) A kind of Traditional Chinese medicinal health-care wine
CN107184766A (en) A kind of and spleen and tonifying kidney composition
CN1334114A (en) Chinese medicine for treating mastoplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication